Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000927016-03-000751
Filing Date
2003-02-14
Accepted
2003-02-14 13:46:14
Documents
5
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.txt 10-Q 72870
3 AMENDMENT NO.1 TO LICENSING AGREEMENT dex10128.txt EX-10.128 14506
4 SUPPLY AGREEMENT dex10129.txt EX-10.129 86255
5 SARBANES OXLEY CERTIFICATE GLENN L. COOPER dex991.txt EX-99.1 1345
6 SARBANES OXLEY CERTIFICATE MICHAEL W. ROGERS dex992.txt EX-99.2 1377
  Complete submission text file 0000927016-03-000751.txt   178522
Mailing Address ONE LEDGEMONT CENTER 99 HAYDEN AVE LEXINGTON MA 02421
Business Address ONE LEDGEMONT CENTER 99 HAYDEN AVE LEXINGTON MA 02421 6178618444
INDEVUS PHARMACEUTICALS INC (Filer) CIK: 0000854222 (see all company filings)

EIN.: 043047911 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-18728 | Film No.: 03565758
SIC: 2834 Pharmaceutical Preparations